← Eichor
Study identifier: NCT06529029 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy

Condition: Suicidal Ideation · Major Depressive Disorder · Schizo Affective Disorder  ·  Sponsor: Michigan State University

PhasePhase 2/Phase 3
Planned participants30
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

This protocol proposes an initial randomized clinical trial that includes all patients with suicidal ideation (SI) at baseline, and with SI as the primary outcome measure to examine whether Right Unilateral Low-Amplitude Pulse - Seizure Therapy (RUL LAP-ST) treatment has more magnitude and rate of remission of SI as conventional pulse amplitude Right Unilateral Electroconvulsive Therapy (RUL ECT) (based on our prior secondary analysis). Our central hypothesis is that RUL LAP-ST has significantly less cognitive/memory side effects (no memory side effects were noted in our prior studies for 500mA and 600mA) and thus is more favorable in terms of side effects compared to RUL conventional pulse amplitude ECT, while maintaining better anti-suicidal effect.

This description comes directly from the study's public registry record.

Talk to the study team

Nagy A Youssef, MD, PhD  ·  616-281-6451  ·  nagy.youssef@pinerest.org

Janelle M Kassien, LMSW  ·  616-980-7516  ·  janelle.kassien@pinerest.org

Always discuss trial participation with your own doctor first.

Locations (1)

Pine Rest Christian Mental Health ServicesGrand Rapids, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06529029